论文部分内容阅读
目的:探析步长脑心通治疗稳定性心绞痛的临床效果。方法:选择二年来的门诊稳定性心绞痛病例68例为研究对象,随机分为两组,其中给予对照组常规治疗,观察组在对照组治疗的基础上,再给予步长脑心通联合治疗,对比分析两组的治疗效果。结果:经过1个疗程治疗后,观察组的治疗总有效率明显高于对照组,并且与对照组相比,观察组的心绞痛发作次数少、持续时间短,组间对比差异有统计学意义(P<0.05)。结论:临床上运用步长脑心通治疗冠心病稳定性心绞痛,不仅可以减少心绞痛发作次数、缩短发作时间,在一定程度上还能提高治疗效果,使患者的预后生活质量得到改善。
Objective: To explore the clinical effect of Stephenaxutong on stable angina pectoris. Methods: Sixty-eight outpatients with stable angina pectoris in the past two years were selected as the research object and randomly divided into two groups. The patients in the control group were given routine treatment. The observation group was treated with the combination of “Stephensu Naoxintong” Comparative analysis of two groups of treatment. Results: After one course of treatment, the total effective rate of the observation group was significantly higher than that of the control group. Compared with the control group, the observation group had fewer angina attacks and shorter duration, and the differences between the two groups were statistically significant ( P <0.05). Conclusion: The clinical application of Stephenxintong in the treatment of stable angina pectoris can not only reduce the number of angina pectoris and shorten the onset time, but also improve the therapeutic effect to some extent, and improve the prognosis quality of life of patients.